1. Home
  2. MGTX

as of 03-17-2026 3:40pm EST

$7.64
$0.06
-0.72%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Founded: 2015 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 610.1M IPO Year: 2018
Target Price: $23.83 AVG Volume (30 days): 297.7K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.61 EPS Growth: -42.28
52 Week Low/High: $4.73 - $9.73 Next Earning Date: N/A
Revenue: $33,279,000 Revenue Growth: 137.42%
Revenue Growth (this year): -20.23% Revenue Growth (next year): 569.48%
P/E Ratio: -4.76 Index: N/A
Free Cash Flow: -109450000.0 FCF Growth: N/A

AI-Powered MGTX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 75.00%
75.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q3

Q3 2025 Earnings

8-K SELL

Nov 13, 2025 · 100% conf.

AI Prediction SELL

1D

-1.51%

$8.14

5D

-8.51%

$7.56

20D

-15.13%

$7.01

Price: $8.26 Prob +5D: 0% AUC: 1.000
0001104659-25-110883

MeiraGTx Holdings plc_November 13, 2025 0001735438false00017354382025-11-132025-11-13 ​ ​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2025 MeiraGTx Holdings plc (Exact name of registrant as specified in its charter) ​ ​

Cayman Islands

001-38520

98-1448305

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

​ 655 Third Avenue, Suite 1115 New York, NY 10017 (Address of principal executive offices) (Zip code) ​ (646) 860-7985 (Registrant’s telephone number, including area code) Not applicable (Former name or former address, if changed since last report) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ​

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​ Securities registered pursuant to Section 12(b) of the Act: ​

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Ordinary Shares, $0.00003881 par value per share

MGTX

The Nasdaq Global Select Market

​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐ ​ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ ​ ​ ​

Item 2.02. Results of Operations and Financial Condition.

On November 13, 2025, MeiraGTx Holdings plc (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. ​ The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. ​ Item 9.01.Financial Statements and Exhibits. ​ (d)Exhibits. ​ ​

Exhibit No.

Description

99.1 ​ Press release of MeiraGTx Holdings plc, dated November 13, 2025.

104 ​ Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).

​ ​ ​

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ​ ​

Date: November 13, 2025 ​

​ ​

MEIRAGTX HOLDINGS PLC

​ ​

​ ​

​ By: /s/ Richard Giroux

​ Name: Richard Giroux

​ Title: Chief Financial Officer and Chief Operating Officer

​ ​ ​

3

2025
Q2

Q2 2025 Earnings

8-K

Aug 14, 2025

0001558370-25-011478

0001735438false00017354382025-08-142025-08-14 ​ ​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2025 MeiraGTx Holdings plc (Exact name of registrant as specified in its charter) ​ ​

Cayman Islands

001-38520

98-1448305

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

​ 450 East 29th Street, 14th Floor New York, NY 10016 (Address of principal executive offices) (Zip code) ​ (646) 860-7985 (Registrant’s telephone number, including area code) Not applicable (Former name or former address, if changed since last report) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ​

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​ Securities registered pursuant to Section 12(b) of the Act: ​

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Ordinary Shares, $0.00003881 par value per share

MGTX

The Nasdaq Global Select Market

​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐ ​ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ ​ ​ ​

Item 2.02. Results of Operations and Financial Condition.

On August 14, 2025, MeiraGTx Holdings plc (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. ​ Item 9.01.Financial Statements and Exhibits. (d)Exhibits. Exhibit No.

Description

99.1 ​ Press release of MeiraGTx Holdings plc, dated August 14, 2025.

104 ​ Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).

​ ​ ​

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ​ Date: August 14, 2025 ​

​ ​

MEIRAGTX HOLDINGS PLC

​ ​

​ ​

​ By: /s/ Richard Giroux

​ Name: Richard Giroux

​ Title: Chief Financial Officer and Chief Operating Officer

​ ​ ​

3

2025
Q1

Q1 2025 Earnings

8-K

May 13, 2025

0001558370-25-007497

0001735438false00017354382025-05-132025-05-13 ​ ​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025 MeiraGTx Holdings plc (Exact name of registrant as specified in its charter) ​ ​

Cayman Islands

001-38520

98-1448305

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

​ 450 East 29th Street, 14th Floor New York, NY 10016 (Address of principal executive offices) (Zip code) ​ (646) 860-7985 (Registrant’s telephone number, including area code) Not applicable (Former name or former address, if changed since last report) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ​

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​ Securities registered pursuant to Section 12(b) of the Act: ​

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Ordinary Shares, $0.00003881 par value per share

MGTX

The Nasdaq Global Select Market

​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐ ​ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ ​ ​ ​

Item 2.02. Results of Operations and Financial Condition.

On May 13, 2025, MeiraGTx Holdings plc (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. ​ Item 9.01.Financial Statements and Exhibits. (d)Exhibits. Exhibit No.

Description

99.1 ​ Press release of MeiraGTx Holdings plc, dated May 13, 2025.

104 ​ Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).

​ ​ ​

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ​ Date: May 13, 2025 ​

​ ​

MEIRAGTX HOLDINGS PLC

​ ​

​ ​

​ By: /s/ Richard Giroux

​ Name: Richard Giroux

​ Title: Chief Financial Officer and Chief Operating Officer

​ ​ ​

3

Share on Social Networks: